Mark Sulkowski, M.D.
- Associate Professor of Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore MD
- Medical Director, Viral Hepatitis Center, Divisions of Infectious Diseases and Gastroenterology/Hepatology at the Johns Hopkins University School of Medicine in Baltimore, MD
- 4 textbook chapters
- 14 Non-peer reviewed articles
- 50 Peer-reviewed scientific articles
- Fellowship, Infectious Diseases: Johns Hopkins University School of Medicine, Baltimore, Maryland
- Residency: Duke University Medical Center, Durham, North Carolina
- Internship: Duke University Medical Center, Durham, North Carolina
- MD: Temple University School of Medicine, Philadelphia, Pennsylvania
- American Association for the Study of Liver Diseases
- European Association for the Study of the Liver
- Infectious Diseases Society of America
- Clinical trials and outcomes research related to the management of chronic hepatitis C including novel antiviral agents
- Outcomes research related to HCV and liver disease in HIV-infected persons
- Co-investigator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Hepatitis B Clinical Research Network
- Co-investigator: AIDS Clinical Trials Group (ACTG)
- Dr. Sulkowski has received institutional research grants (to Johns Hopkins University) and/or served as a scientific consultant/advisor for: Boehringer Ingelheim, Human Genome Sciences, Vertex, Indenix, Merck, Valeant, BMS, Tibotec, Roche, and Schering, and government grants or research funding (R01 DA13806 and R01DA16065)
Mark Sulkowski, M.D. is a sample topic from the Johns Hopkins Author Bios.
Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Learn more.
Last updated: January 21, 2014